# A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia

> **NCT00829647** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Scripps Health**

## Conditions studied

- Chronic Lymphocytic Leukemia
- Leukemia

## Interventions

- **DRUG:** dasatinib and lenalidomide

## Key facts

- **NCT ID:** NCT00829647
- **Lead sponsor:** Scripps Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-01
- **Primary completion:** 2009-12
- **Final completion:** 2016-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to enroll
- **Last updated:** 2019-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00829647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00829647, "A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00829647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*